Thursday January 19, 8:00 am ET Grant Life Sciences enters into Memorandum of Understanding (MOU) with U.S. State Department's 'Bio-Industry Initiative' (BII)
some info ...
The mission of BII is to counter the threat of bioterrorism through targeted transformation of former Soviet biological research and production capacities. Rao said this unique international program has "incredible potential," both in joint efforts to combat terrorism and in opening up significant opportunities for U.S. industry.
BII's partner organizations include the International Science and Technology Center (ISTC) in Moscow, a multinational nonproliferation program; the Boston-based Center for Integration of Medicine and Innovative Technology (CIMIT), a consortium of Harvard teaching hospitals, MIT, and Draper Laboratory; and its Russian counterpart, TEMPO, the Non-commercial Partnership Center of Modern Medical Technology. Through these partnerships, doctors and scientists in the United States and Russia are working together to develop anticancer vaccines and other exciting medical breakthroughs, said Rita Watson, communications director for CIMIT. link for the rest (old article, no mention of glif) http://www.ransac.org/Publications/News/Nuclear%20News/6242004105647AM.html#1C
09/22/2005 (16:51 ET) Grant Life Sciences Awarded Patent for Vital Components of Blood-Based Cervical Cancer Test; Patent Marks Major Company Milestone and Significant Step toward Product Commercialization - Business Wire
11/08/2005 (09:03 ET) Grant Life Sciences begins generating revenues from sales of its rapid-test product family licensed from AccuDx - Business Wire
01/09/2006 (00:07 ET) Grant Life Sciences To Exhibit At WealthExpo January 12-14 In Houston - Investrend
Last Trade: 0.022 Change: 0.000 ( +0.000 %) Previous Close: 0.022 Today's Open: 0.022 # of Trades: 16 Volume: 1,024,900 Avg. # of Trades: 47 Avg. Daily Volume: 4,138,525
People who say it cannot be done should not interrupt the person doing it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.